Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3176 |
|
| Actual shortage: | 259 (8%) | |
| Anticipated shortage: | 5 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2903 (91%) | |
Discontinuation Reports |
355 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 333 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
33 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CINACALCET | 60MG | TABLET | Resolved | 2024-02-02 | 2024-03-22 | 218382 |
| APO-TICAGRELOR | 60MG | TABLET | Resolved | 2024-05-31 | 2024-07-19 | 229398 |
| APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-06-06 | 2024-08-09 | 229755 |
| APO-CINACALCET | 60MG | TABLET | Resolved | 2024-06-13 | 2024-09-20 | 230460 |
| APO-DEXLANSOPRAZOLE | 60MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2024-06-14 | 2024-08-15 | 230579 |
| APO-GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-06-27 | 2024-08-07 | 231493 |
| APO-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2024-07-18 | 2024-09-20 | 233325 |
| APO-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2024-07-18 | 2024-08-22 | 233358 |
| APO-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2024-08-22 | 2024-09-20 | 235692 |
| APO-COLESEVELAM | 625MG | TABLET | Resolved | 2022-03-11 | 2022-04-01 | 156537 |
| APO-COLESEVELAM | 625MG | TABLET | Resolved | 2022-11-04 | 2023-02-09 | 173826 |
| APO-COLESEVELAM | 625MG | TABLET | Resolved | 2023-04-21 | 2023-07-27 | 190011 |
| APO-COLESEVELAM | 625MG | TABLET | Resolved | 2023-11-17 | 2023-12-22 | 210674 |
| APO-COLESEVELAM | 625MG | TABLET | Resolved | 2024-01-19 | 2024-06-27 | 216646 |
| APO-RIVASTIGMINE | 6MG | CAPSULE | Resolved | 2017-07-26 | 2018-03-27 | 17322 |
| APO-PACLITAXEL INJECTABLE | 6MG | SOLUTION | Actual shortage | 2017-08-14 | 2017-10-05 | 19133 |
| APO-HYDROMORPHONE CR | 6MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-01-03 | 2020-04-04 | 71124 |
| APO-RIVASTIGMINE | 6MG | CAPSULE | Resolved | 2019-07-03 | 2019-10-07 | 88360 |
| APO-RIVASTIGMINE | 6MG | CAPSULE | Resolved | 2021-12-03 | 2021-12-13 | 150440 |
| APO-RIVASTIGMINE | 6MG | CAPSULE | Actual shortage | 2024-09-20 | 2024-09-20 | 238239 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-CETIRIZINE | Discontinued | 2018-05-31 | 2018-05-31 | 50998 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-09-07 | 2018-09-15 | 60241 | ||
| APO-CYCLOSPORINE ORAL SOLUTION | Discontinued | 2018-09-07 | 2018-09-15 | 60408 | ||
| APO-FAMOTIDINE TAB 20MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60477 | ||
| APO-FAMOTIDINE TAB 40MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60480 | ||
| APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
| APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
| APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
| APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
| APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 | ||
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 |